Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16245-16251
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16245
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16245
Patients with resistant Helicobacter pylori strains | 95%CI | |
No previous eradication therapy (n = 29) | ||
Clarithromycin | 2 (6.9) | 0.03-0.18 |
Metronidazole | 5 (17.2) | 0.03-0.34 |
Levofloxacin | 4 (13.8) | 0.02-0.24 |
One previous eradication therapy (n = 13) | ||
Clarithromycin | 7 (53.8) | 0.30-0.98 |
Metronidazole | 9 (69.2) | 0.30-0.98 |
Levofloxacin | 3 (23.1) | 0.04-0.59 |
Two or more previous eradication therapies (n = 24) | ||
Clarithromycin | 20 (83.3) | 0.63-0.97 |
Metronidazole | 20 (83.3) | 0.69-0.99 |
Levofloxacin | 8 (33.3) | 0.09-0.47 |
Rifabutin | 3 (12.5) | 0.04-0.12 |
-
Citation: Selgrad M, Tammer I, Langner C, Bornschein J, Meißle J, Kandulski A, Varbanova M, Wex T, Schlüter D, Malfertheiner P. Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of
Helicobacter pylori infection. World J Gastroenterol 2014; 20(43): 16245-16251 - URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16245.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16245